Miami University

Tacrine does not alleviate rewarded alternation deficits produced by NMDA receptor antagonism. The purpose of this study was to determine if tacrine (THA), an acetylcholinesterase inhibitor used in the treatment of Alzheimer’s Disease, could alleviate spatial memory impairment produced by the NMDA receptor antagonist, MK-801. ................
................

In order to avoid copyright disputes, this page is only a partial summary.